Tapentadol

Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026

Tapentadol is a Schedule II opioid analgesic with mu-opioid receptor agonism and norepinephrine reuptake inhibition, used for selected moderate to severe acute pain and chronic pain formulations when opioid therapy is appropriate. It carries opioid boxed warnings for addiction, abuse, misuse, life-threatening respiratory depression, accidental ingestion, neonatal opioid withdrawal, and dangerous sedation or respiratory depression with benzodiazepines or other CNS depressants.

Exploratory record, not a reviewed medical publication.

See the editorial and medical-review policies for the publication gate.

This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.

In short

What the research says.

A quick, data-only summary. The full evidence, dosing, and sources are below.

Tapentadol is a Schedule II opioid analgesic with mu-opioid receptor agonism and norepinephrine reuptake inhibition, used for selected moderate to severe acute pain and chronic pain formulations when opioid therapy is appropriate. NutriStack rates the supporting evidence as strong. Common adult dosing is Immediate-release adults: commonly 50 to 100 mg every 4 to 6 hours as needed; do not exceed 700 mg on day 1 or 600 mg/day on subsequent days. Extended-release: typically starts at 50 mg every 12 hours and is titrated cautiously; do not exceed 500 mg/day and do not use ER for as-needed acute pain., though a prescriber sets the actual dose. This profile indexes 3 sources.

What it's good for

Treatment of moderate to severe acute pain requiring opioid analgesia¹
Extended-release treatment of severe chronic pain requiring around-the-clock opioid therapy
Neuropathic pain associated with diabetic peripheral neuropathy for selected extended-release labeling¹
Alternative opioid option when benefits outweigh risks^1,2

What to watch for

Nausea
Vomiting
Constipation
Significant respiratory depression³
Acute or severe bronchial asthma in an unmonitored setting or without resuscitative equipment

The bottom line

Evidence rating strong. Most-documented uses: treatment of moderate to severe acute pain requiring opioid analgesia, extended-release treatment of severe chronic pain requiring around-the-clock opioid therapy, neuropathic pain associated with diabetic peripheral neuropathy for selected extended-release labeling. 3 sources indexed (2009–2026), with 0 interaction records on file.

The science

How it works, mechanistically.

Core mechanism

Tapentadol activates mu-opioid receptors in the central nervous system to reduce pain transmission and alters descending inhibitory pain pathways by inhibiting norepinephrine reuptake. Its opioid activity causes analgesia but also respiratory depression, sedation, constipation, physical dependence, and overdose risk. The monoaminergic component creates warnings for serotonin syndrome when combined with serotonergic drugs or supplements, although norepinephrine reuptake inhibition is more prominent than serotonin reuptake inhibition.^2,3

Class

Centrally acting opioid analgesic and norepinephrine reuptake inhibitor

Dosing

Dosing & protocol.

Common range

Immediate-release adults: commonly 50 to 100 mg every 4 to 6 hours as needed; do not exceed 700 mg on day 1 or 600 mg/day on subsequent days. Extended-release: typically starts at 50 mg every 12 hours and is titrated cautiously; do not exceed 500 mg/day and do not use ER for as-needed acute pain.

Recommended form

Immediate-release tablet for short-term acute use or extended-release tablet for carefully selected chronic around-the-clock therapy; swallow ER tablets whole

May be taken with or without food. Do not crush, chew, or dissolve extended-release tablets. Avoid alcohol, sedatives, and serotonergic supplements unless the prescriber explicitly approves.

Safety

Full safety detail.

Side effects

Nausea
Vomiting
Constipation
Dizziness
Somnolence
Headache
Pruritus
Respiratory depression
Hypotension
Physical dependence and withdrawal
Serotonin syndrome with serotonergic agents
Seizures in susceptible patients
Adrenal insufficiency with chronic opioid use
Overdose and death

Contraindications

Significant respiratory depression³
Acute or severe bronchial asthma in an unmonitored setting or without resuscitative equipment
Known or suspected gastrointestinal obstruction including paralytic ileus
Known hypersensitivity to tapentadol^2,3
Use with monoamine oxidase inhibitors or within 14 days of MAOI use
Avoid ER product in opioid non-tolerant patients when labeling requires tolerance for higher strengths^1,2

Sources

Sources, by evidence tier.

Numbered references. Citations throughout the page link here.

Reviews & position papers

1CDC Clinical Practice Guideline for Prescribing Opioids for PainDowell D et al. · MMWR Recommendations and Reports · 2022
Guideline supports risk assessment, naloxone consideration, and caution with CNS depressants.
2Tapentadol: a review of experimental pharmacology studies, clinical trials, and abuse liabilityTzschentke TM et al. · Drugs · 2009
Review describes dual mechanism, analgesic efficacy, and opioid-related adverse effects.

Reference material

3Tapentadol Hydrochloride Tablets US Prescribing InformationURLU.S. National Library of Medicine · DailyMed · 2026
Labeling describes Schedule II status, opioid boxed warnings, contraindications, dosing, respiratory depression, CNS depressant risk, and serotonin syndrome.

FAQ

Common questions.

Quick answers about Tapentadol, drawn from the data on this page.

What is Tapentadol?

What is Tapentadol used for?

Commonly cited benefits of Tapentadol include: Treatment of moderate to severe acute pain requiring opioid analgesia; Extended-release treatment of severe chronic pain requiring around-the-clock opioid therapy; Neuropathic pain associated with diabetic peripheral neuropathy for selected extended-release labeling; Alternative opioid option when benefits outweigh risks. NutriStack rates the overall evidence as strong.

What is a typical dose of Tapentadol?

A typical adult dose of Tapentadol is Immediate-release adults: commonly 50 to 100 mg every 4 to 6 hours as needed; do not exceed 700 mg on day 1 or 600 mg/day on subsequent days. Extended-release: typically starts at 50 mg every 12 hours and is titrated cautiously; do not exceed 500 mg/day and do not use ER for as-needed acute pain.. The commonly recommended form is Immediate-release tablet for short-term acute use or extended-release tablet for carefully selected chronic around-the-clock therapy; swallow ER tablets whole. These are general ranges, not personalized advice; confirm the right dose with a clinician.

What are the side effects of Tapentadol?

Reported side effects include nausea, vomiting, constipation, dizziness, somnolence, headache. This is educational information; check with a healthcare professional before use.

How strong is the evidence for Tapentadol?

NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.

Use this with your stack

Tapentadol in NutriStack.

Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.

Download on the App Store → Read the methodology